ArrowMark Colorado Holdings LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
ArrowMark Colorado Holdings LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$4,223,000
+125.1%
66,5720.0%0.04%
+100.0%
Q3 2019$1,876,000
+6.3%
66,5720.0%0.02%
+11.8%
Q2 2019$1,764,000
+44.4%
66,5720.0%0.02%
+41.7%
Q1 2019$1,222,000
+47.8%
66,5720.0%0.01%
+33.3%
Q4 2018$827,000
-35.2%
66,5720.0%0.01%
-18.2%
Q3 2018$1,276,00066,5720.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders